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ABSTRACT
Cells universally adapt to ischemic conditions by turning on a transcription factor 
hypoxia-inducible factor (HIF), in which its role is known to differ widely across many 
different types of cells. Given that microglia have been reported as an essential mediator 
of neuroinflammation in many brain diseases, we examined the role of HIF in microglia 
in the progression of an acute phase of ischemic stroke by challenging our novel strains 
of myeloid-specific Hif-1α or Hif-2α knockout (KO) mice created by Cre-loxP system 
via middle cerebral artery occlusion (MCAO). We observed that Hif-1α but not Hif-2α 
KO mice exhibited an improved recovery compared to wild-type (WT) mice determined 
by behavioral tests. Immunostaining analyses revealed that there were increased 
numbers of both mature and immature neurons while microglia and apoptotic cells 
were significantly decreased in the dentate gyrus of Hif-1α KO mice following MCAO. By 
isolating microglia with fluorescence-activated cell sorter, we found that HIF-1α-deficient 
microglia were impaired in phagocytosis, reactive oxygen species (ROS) production, and 
tumor necrosis factor-α (TNF-α) secretion. We further observed a significant decrease in 
the expression of Cd36 and milk fat globule-epidermal growth factor 8 (Mfg-e8) genes, 
both of which contain hypoxia-responsive element (HRE). Knocking down either of 
these genes in BV2 microglial cells was sufficient to abrogate HIF-mediated increase in 
phagocytosis, production of intracellular ROS, or TNF-α secretion. Our results therefore 
suggest that HIF-1α in microglia is a novel therapeutic target to protect neuronal survival 
following an acute phase of ischemic stroke.
INTRODUCTION
Ischemic stroke occurs by blood clots obstructing 
the blood flow to the brain leading to permanent neuronal 
disabilities in the affected individuals [1]. Cells respond to 
ischemic conditions by activating hypoxia-inducible factor 
(HIF), a transcription factor regulating numerous genes 
involved in cellular survival, migration, metabolism, and 
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angiogenesis [2]. HIF is a heterodimer composed of an 
oxygen-sensitive α (HIF-α) subunit and oxygen-insensitive 
β subunit [2]. To date, three HIF-α isoforms (HIF-1α, HIF-
2α, and HIF-3α) have been identified where HIF-α form is 
being hydroxylated under well-oxygenated conditions by 
proline hydroxylases, which eventually becomes degraded 
by proteasome via von Hippel Lindau E3 ubiquitin ligase 
complex [3]. Under hypoxic conditions, HIF-α cannot 
be hydroxylated due to the lack of oxygen inactivating 
proline hydroxylase activity [4]. HIF-α is then stabilized in 
the cytoplasm where it interacts with HIF-1β, followed by 
translocation into the nucleus where it binds to hypoxia-
responsive elements (HREs) of HIF target genes [4].
Microglia are brain-resident macrophages 
rapidly responding to variety of stimuli in response 
to host-defense mechanisms protecting the brain 
against pathogens and injuries including ischemic 
stroke [5]. Upon activation, they are known to undergo 
morphological changes, upregulate markers including 
CD68 and major histocompatibility complex class II [6], 
and produce proinflammatory cytokines such as tumor 
necrosis factor-ɑ (TNF-ɑ) and interleukin-6 (IL-6) [6]. 
Activated microglia are commonly observed in many brain 
diseases such as stroke [7], Alzheimer’s disease [8], and 
Parkinson’s disease [9] and have recently been reported 
as a key mediator for neuroinflammation [10]. It is highly 
controversial whether activated microglia are detrimental 
or beneficial in the brain disease progression as some of 
recent studies have suggested that they are essential for 
protecting neurons by removing apoptotic cells and debris 
via phagocytic processes [11] or by trimming the neuronal 
synapses to regulate synaptic development [12].
It has been previously reported that microglia 
exposed to hypoxic conditions produce proinflammatory 
mediators such as nitric oxide (NO) [13] and TNF-ɑ [14] 
in a HIF-1-dependent mechanism. However, it is still 
poorly understood how HIF regulates microglial functions 
in ischemic stroke. Here we demonstrate by using our 
novel strain of myeloid-specific Hif-ɑ knockout (KO) 
mice that HIF-1α, but not HIF-2α in microglia critically 
affects neuronal survival in mice following ischemic 
stroke by regulating CD36 or milk fat globule-epidermal 
growth factor 8 (MFG-E8)-mediated phagocytosis, which 
in turn leads to reactive oxygen species (ROS) and TNF-α 
production. We therefore believe that HIF-1α in microglia 
may be a novel therapeutic target to promote neuronal 
survival in the hippocampus at the acute phase of ischemic 
stroke.
RESULTS
Myeloid-specific Hif-1α KO mice exhibit faster 
behavioral recovery following MCAO
We first confirmed that MCAO resulted in an 
obstruction of blood flow (Figure 1A), development of 
infarcted region (Figure 1B), and an increased HIF-1α 
protein expression (Figure 1C) in the ipsilateral side of 
the brain. We further observed that mice subjected to 
MCAO exhibited a significant impairment in behavior as 
determined by open-field (Figure 1D) and rotarod (Figure 
1E) tests. To determine whether our hS100A8 myeloid 
promoter targets microglia in the brain, we stained the 
brain of Rosa-eYFP reporter mice crossbred with Cre-
hS100A8 mice. We observed eYFP-positive cells only in 
the brain of mice bearing Cre-recombinase gene (Figure 
1F) and that these cells were highly co-localized with 
Iba-1-positive microglia (Figure 1F) but not with NeuN-
positive neurons (Figure 1G). To determine a role of 
HIF-1 in microglia in ischemic stroke, we challenged our 
novel strain of myeloid-specific Hif-a KO mice (hereafter 
denoted as Hif-α KO mice) with MCAO. We found in 
Hif-1α KO mice that Hif-1α gene deletion efficiency 
was approximately 70% in Iba-1-positive microglia 
isolated by fluorescence-activated cell sorting (FACS) 
(Supplementary Figure 1A). Upon challenging Hif-α KO 
mice with MCAO, we observed that Hif-1α (Figure 1H 
and 1I) but not in Hif-2α KO mice (Figure 1H and 1I) 
exhibited a significantly faster behavioral recovery, as 
determined by open-field (Figure 1H) and rotarod (Figure 
1I) tests compared to the wild-type (WT) control mice.
Myeloid-specific Hif-1α KO mice have fewer 
infiltrating microglia and apoptotic neurons in 
the hippocampus following MCAO
To determine how Hif-1α KO mice exhibited a 
faster recovery following MCAO, we examined microglia 
and neurons in the hippocampal areas of the ipsilateral 
side of the brain by immunostaining. We observed that 
while the numbers of Iba-1-positive microglia and NeuN-
positive neurons were similar at d1 and d3 following 
MCAO between Hif-1α KO and WT mice (Figure 2), 
Iba-1-positive microglia were significantly fewer at d7 
while NeuN-positive neurons were significantly increased 
at d5 and d7 in Hif-1α KO mice (Figure 2). To examine 
whether Hif-1α KO mice without MCAO would exhibit 
any defects in the numbers of neurons or microglia, we 
performed behavioral tests and immunostaining in Hif-1α 
KO or WT mice not challenged with MCAO. We found 
that behavioral outcome (Figure 3A and 3B) and the 
numbers of Iba-1-positive microglia and NeuN-positive 
neurons (Figure 3C and 3D) were all comparable between 
Hif-1α KO and WT mice.
The above results suggest that the increased number of 
neurons in Hif-1α KO mice following MCAO could be due 
to an increased level of cellular proliferation or a decreased 
level of apoptosis. To test these hypotheses, we performed 
immunostaining by using antibodies against Ki67 to detect 
proliferating cells, doublecortin (DCX) to stain newly-born 
immature neurons, or cleaved caspase-3 (CC3) to detect 
apoptotic cells in the dentate gyrus of hippocampus where 
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Figure 1: Stroke induction via middle cerebral artery occlusion (MCAO) demonstrates that our novel strain 
of myeloid-specific Hif-1α knockout (Hif-1α KO) mice exhibit an improved behavioral recovery than wild-type 
(WT) mice. (A) Blood flow to the brain of wild-type (WT) mice during sham (left) or MCAO (right) surgery, as monitored by 
Laser Doppler Flowmetry. (B) Infarct regions (white) in the WT brain at 24 hr after MCAO stained with triphenyl tetrazolium 
tetrachloride. (C) Immunostaining of the WT brain at the contralateral (Contra; left) or ipsilateral (Ipsi; right) side at 24 hr post-MCAO 
for Iba-1 (red) to stain for microglia or HIF-1α (green). (D) Open-field behavioral test measuring exploratory behavior of WT mice 
subjected to sham or MCAO, measured for 10 min. (E) Rotarod test of mice WT subjected to sham or MCAO measuring the speed 
of rotarod at which mice fall. Data in D and E are the mean ± s.e.m. (n ≥ 5 mice for each group). (F) Immunofluorescence staining 
of the brain of Rosa26-eYFP reporter mice crossbred with Cre-hS1008 mice for Iba-1 (red). Note that only those mice bearing Cre-
transgene (hS100A8-Cre;Rosa26-eYFP, right) demonstrated YFP (yellow) signal. (G) Immunofluorescent images of the Rosa26-eYFP 
reporter mice bearing Cre-transgene as in F stained using NeuN antibodies (red) to detect neuronal cells. For C, F, and G, nuclei are 
counterstained with DAPI (blue) and the scale bars denote 100 μm. (H) Open-field and (I) rotarod tests for WT (n ≥ 4), Hif-1ɑ KO 
(n = 5; green bars), or Hif-2ɑ KO (n = 5; blue bars) mice challenged with MCAO. Data in H and I are the mean ± s.e.m. with * and ** 
indicate P < 0.05 and < 0.01, respectively, determined by Student’s t-test.
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adult neurogenesis in mice is known to predominantly 
occur [15]. We observed that the numbers of Ki67- or DCX-
positive cells were significantly increased in Hif-1α KO 
mice than those in WT control at d5 (Figure 4A and 4B) and 
d7 (Figure 4C and 4D) post-MCAO. Furthermore, Ki67-
positive cells were highly co-localized with DCX-positive 
cells in the granular layer in Hif-1α KO mice (Figure 4A 
and 4C), suggesting that Hif-1α KO mice have proliferating 
neuroblasts in the hippocampus following MCAO. In Hif-2α 
KO mice we observed similar numbers of Ki67- or DCX-
positive cells compared to WT mice (Figure 4C and 4D). 
Immunostaining for neurons and apoptotic cells by using 
NeuN and caspase-3 or CC3 antibodies revealed that the 
numbers of neurons were increased (Figure 5A and 5B) 
while those of apoptotic cells were significantly decreased 
(Figures  5A, 5C–5E) in Hif-1α KO mice compared to those 
in WT control mice at d7 post-MCAO. We did not observe 
such differences in Hif-2α KO following MCAO (Figure 5).
HIF-1α regulates microglial phagocytosis and 
abilities to produce ROS and TNF-α under 
ischemic conditions
We hypothesized that fewer infiltrating microglia and 
higher numbers of neurons in Hif-1α KO mice following 
MCAO were due to the deficiency of HIF-1α impairing 
microglial functions such as migration and phagocytosis. 
To test our hypothesis, we isolated Iba-1-positive microglia 
Figure 2: Decreased infiltrating microglia while increased number of neurons are observed in Hif-1α KO mice following 
MCAO. (A) Immunostaining of the hippocampal areas of WT or Hif-1α KO mice following MCAO using Iba-1 (red) and NeuN (green) 
antibodies. Nuclei are counterstained with DAPI (blue). Scale bars denote 100 μm. (B) Quantification of results from A for Iba-1 (left) and 
NeuN (right). Data are the mean ± s.e.m. with * and ** indicate P < 0.05 and < 0.01, respectively as determined by Student’s t-test.
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by FACS from WT or Hif-1α KO mice at d5 post-MCAO 
and examined microglial functions including phagocytosis, 
migration, ROS production, and TNF-α secretion. We 
observed that Hif-1α-deficient microglia exhibited 
significantly impaired phagocytic uptake of fluorescent 
beads compared to WT microglia (Figure 6A). This impaired 
phagocytosis was not observed in microglia isolated from Hif-
1α KO mice not subjected to MCAO (Figure 6A), suggesting 
that HIF-1α regulates phagocytic activities in microglia 
selectively under hypoxic conditions. Phagocytic activation 
is also known to regulate other functions of macrophages/
microglia such as chemotaxis [16] and production of 
cytokines or ROS [17]. Upon examining chemotaxis, 
intracellular ROS levels, and TNF-α concentrations in 
FACS-isolated microglia, we observed that HIF-1α-deficient 
microglia exhibited significant impairments in chemotaxis 
(Figure 6B), and in production of ROS (Figure 6C and 6D) 
and TNF-α (Figure 6E) compared to WT microglia.
Cd36 or Mfg-e8 phagocytic gene mediates HIF-
1α-regulated microglial functions
Because HIF-1 possesses numerous downstream target 
genes, we next sought how HIF-1α regulates microglial 
functions by examining gene expression changes in microglia 
isolated from Hif-1α KO or WT mice at d5 post-MCAO 
against a panel of pathways involved in phagocytosis, 
chemotaxis, and inflammatory responses. We observed 
that Cd36 and Mfg-e8 phagocytic gene expressions were 
significantly decreased in HIF-1α-deficient microglia 
(Figure 7A), suggesting that they may be HIF-1-regulated 
genes. Consistent with this, Cd36 and Mfg-e8 contained 
5’-RCGTG-3’ putative hypoxia-responsive element (HRE) 
binding sites [18] at 10 kb upstream of transcription start 
sites (Supplementary Figure 1B), indicating that they are 
downstream targets of HIF. To determine whether Cd36 or 
Mfg-e8 can regulate HIF-1α-mediated microglial functions, 
we silenced Hif-1α, Cd36 or Mfg-e8 in BV2 microglial 
cell lines. We observed that phagocytosis (Figure 7B) and 
production of ROS (Figure 7C) and TNF-α (Figure 7D) 
were significantly increased by treatment with CoCl2, a 
HIF mimetic. Silencing Hif-1α effectively decreased HIF-
1α protein levels (Supplementary Figure 1C) and Cd36 or 
Mfg-e8 gene expression only in CoCl2-treated conditions 
(Supplementary Figure 1D). We found that knocking down 
either Cd36 or Mfg-e8 could abrogate HIF-mediated increase 
in phagocytosis (Supplementary Figure 1B) and production of 
ROS (Supplementary Figure 1C) or TNF-α (Supplementary 
Figure 1D) in BV2 cells to the level comparable to Hif-1α 
siRNA (Supplementary Figure 1B–1D). These results suggest 
that phagocytic molecules CD36 and MFG-E8 mediate HIF-
1α-regulated microglial functions.
DISCUSSION
In this study, we report our findings where we 
observed a significantly faster behavioural recovery 
in our myeloid-specific Hif-1ɑ KO mice following 
ischemic stroke challenge. We demonstrate that these 
mice are impaired in HIF-1α-dependent microglial 
phagocytic functions mediated by Cd36 and Mfg-e8, 
which can further regulate other functions such as ROS 
Figure 3: Without MCAO Hif-1α KO mice demonstrate similar behavioral outcome and comparable numbers of 
microglia and neurons to WT mice. (A) Open-field and (B) rotarod tests in WT or Hif-1α KO mice not subjected to MCAO (n = 7 
mice per group). (C) Immunofluorescence staining of the brains using Iba-1 (red) and NeuN (green) antibodies in WT or Hif-1α KO mice 
not challenged with MCAO. Nuclei are counterstained with DAPI shown in blue. Scale bars indicate 100 μm. (D) Quantification of Iba-1 
(upper) or NeuN (lower) area densities in C. Data are the mean ± s.e.m. for at least three independent fields examined per mouse, n = 4 
mice per group.
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Figure 4: Hif-1α KO mice have increased proliferating immature neurons in the dentate gyrus of hippocampus after 
MCAO. (A) Immunostaining images of dentate gyrus of the hippocampal areas in WT or Hif-1α KO mice at d5 post-MCAO for immature 
neurons and proliferating cells by using antibodies against DCX (red) and Ki67 (green), respectively. (B) Quantification of Ki67 (left) and 
DCX (right) area densities from A. (C) Immunofluorescent images of dentate gyrus regions in WT, Hif-1α KO or Hif-2α KO at d7 post-
MCAO for proliferating neurons as in A. Nuclei are shown in blue and scale bars indicate 100 μm. (D) Quantification of Ki67 and DCX 
from C. Data in B and D are the mean ± s.e.m. for at least three independent fields examined per mouse, n ≥ 4 mice per group. *, **, and *** 
denote P < 0.05, 0.01, and 0.001, respectively.
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Figure 5: Decreased apoptotic neurons in the dentate gyrus of hippocampus in Hif-1α KO mice following MCAO. 
Immunofluorescent staining images (A, D) and quantification of the staining results (B, C, and E) in the brain obtained from WT, Hif-1α 
KO or Hif-2α KO at d7 post-MCAO for neurons and apoptotic cells by using NeuN (red; A and D), caspase-3 (green; A), cleaved caspase-3 
(CC3, green; D) antibodies. Nuclei are shown in blue with DAPI counterstain. The scale bars in A and D indicate 100 μm. Data in B, C, and 
E are the mean ± s.e.m. for at least three independent fields examined per mouse, n ≥ 4 mice per group. * and ** indicate P < 0.05 and 0.01, 
respectively, determined by one-way ANOVA (B and C) or Student’s t-test (E).
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and TNF-α production. It has been previously reported 
that microglial expression of CD36, a highly glycosylated 
class B scavenger receptor, steadily increases during 
the acute phase (d3 and d7) of MCAO [19] and that 
inhibition of CD36 not only impairs phagocytosis but also 
attenuates damages and inflammatory responses mediated 
Figure 6: HIF-1α-deficient microglia are impaired in microglial functions including phagocytosis, chemotaxis, and 
production of ROS and TNF-α. (A) Representative images (left) and quantification (right) of phagocytic uptake of fluorescent beads 
in microglia isolated from WT or Hif-1α KO mice at d5 post-MCAO. White boxes are magnified and shown on the right. (B) Representative 
images of transmigrated microglia, prepared as in A towards the lower compartment of modified Boyden chamber containing media 
supplemented with no serum, 10% serum, or IL-4. Quantification of the number of migrated microglia per field is shown in the bar graph. 
(C) Representative images of microglia prepared as in A incubated with DCF-DA. Quantification of FITC-positive area densities are 
shown in the bar graph. Nuclei in A and C are counterstained with DAPI (blue). Scale bars in A, B, and C indicate 100 μm. (D) Histogram 
analyses by FACS for DCF-DA fluorescence intensity in microglia from WT (black) or Hif-1α KO (red) mice, as prepared in A. (E) ELISA 
measurements of TNF-α concentrations at 6 and 12 hr in the supernatant obtained from microglia isolated as in A. Numbers in the bar 
graphs of A, B, C, and E are the mean ± s.e.m. with ** and *** indicate P < 0.01 and < 0.001, respectively.
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Figure 7: HIF-1α-regulated microglial functions are mediated by Cd36 or Mfg-e8. (A) Fold changes in mRNA in primary 
microglia isolated from Hif-1α KO mice compared to those in WT at d5 post-MCAO in pathways including phagocytosis, cell migration, 
and immune responses. (B) Representative images of phagocytic uptake of fluorescent beads (white) in BV2 microglial cells. Quantification 
of the number of phagocytosed beads per cell is shown on the right. (C) Representative images of BV2 cells incubated with DCF-DA (left) 
and quantification (right). White asterisks in the immunofluorescent images indicate magnified regions shown in the inserted white boxes. 
(D) TNF-α levels in the supernatant obtained from BV2 cells with or without transfection. Nuclei in B and C are counterstained by DAPI 
(blue) and scale bars denote 100 μm. Data from A to D are the mean ± s.e.m. for triplicate determinations with *, **, and *** indicate P <0.05, 
<0.01, and < 0.001, respectively.
Oncotarget111517www.impactjournals.com/oncotarget
by cerebral ischemia, leading to better neurological 
functions [20, 21], consistent with our results. MFG-E8, 
also known as lactaherin, is a secretory glycoprotein 
that forms bridges between microglial receptors hence 
linking phosphatidylserine-exposing neurons to ɑVβ3 
and ɑVβV integrins of phagocytic cells [22]. Effects of 
MFG-E8 on ischemic stroke is somewhat controversial. 
A study by Deroide and colleagues [22] have reported 
a larger infarct size in Mfg-e8 KO mice at d7 following 
MCA electrocoagulation through a mechanism of 
inhibiting integrin-mediated IL-1β production. On the 
other hand, Neher and colleagues [23] have demonstrated 
a significantly reduced infarct size and improved motor 
functional recovery in Mfg-e8 KO mice following 
intracerebral injection of endothelin-1. They have 
proposed that delayed phagocytosis of those glutamate-
stressed, phosphatidylserine-exposed neuronal cells by 
microglia may be critical in preserve neuronal functions 
in mice [23].
It is highly controversial whether microglia play 
a beneficial or detrimental role in ischemic stroke. 
While some studies have demonstrated that depletion of 
microglia themselves can lead to an increased neuronal 
injury [24], others have reported neuronal protective 
effects [25]. The complex function of microglia becomes 
even more sophisticated by microenvironmental factors 
such as hypoxia and HIF, the major transcription factor 
activated under hypoxic condition. Although previous 
seminal study by Cramer and colleagues [26] has 
demonstrated that HIF-1α itself has shown a minimal 
effect on bacterial phagocytosis in ‘macrophages’, our 
results demonstrated that HIF-1α, but not HIF-2α exerts 
a major functional regulation in ‘microglia’. It is highly 
likely that different myeloid promoters (i.e., LysM versus 
hS00A8) utilized to create myeloid-specific Hif-α KO 
mice may target different subpopulations of myeloid cells. 
Indeed, we have recently reported that the angiogenic 
phenotype that we have observed in our myeloid-specific 
KO mice of constitutive HIF activation (by von Hippel 
Lindau deletion) was not observed when we created them 
using LysM promoter [27]. A recent study by Ko and 
colleagues [28] has utilized myeloid-specific Hif-1ɑ KO 
mice of LysM promoter and reported that these mice have 
also exhibited improved neurological functions following 
ischemia challenge in a mechanism by which HIF-1α-
deficient microglia recruits less neutrophil infiltration into 
the infarcted regions.
In summary, we report that HIF-1α in microglia after 
stroke may facilitate phagocytosis and other microglial 
functions including chemotaxis, ROS production, and 
TNF-ɑ production through CD36 and/or MFG-E8 hence 
interfering with adult neurogenesis in the acute phase of 
ischemic stroke. Thus, our findings suggest that HIF-1α in 
microglia may be a potential therapeutic target for sparing 
neuronal loss and reducing neuroinflammation, which can 
lead to improved functional recovery in stroke patients.
MATERIALS AND METHODS
Mice
Cre-mediated inactivation of Hif-1α or Hif-2α in 
myeloid cells were accomplished by cross-breeding mice 
having lox-P flanking alleles in HIF-1α (Hif-1αfl/fl, The 
Jackson Laboratory) or HIF-2α (Hif-2αfl/fl, The Jackson 
Laboratory) with transgenic mice bearing the Cre-
recombinase gene under the hS100A8 promoter (Cre-
hS100A8) obtained from Dr. I. L. Weissman at Stanford 
University, as described previously [27]. Cre-hS100A8 
mice were also crossbred with transgenic mice bearing 
lox-P-STOP-eYFP-lox-P under the ubiquitous Rosa26 
promoter (Rosa26-eYFP) obtained from Dr. S.-J. Kang 
at Korea Advanced Institute of Science and Technology 
(KAIST). Mice were maintained in a germ-free 
environment and had access to food and water ad libitum. 
All animal procedures were approved by the Institutional 
Animal Care and Use Committee at Pohang University of 
Science and Technology.
Cell culture conditions
Murine BV2 microglial cell line was kindly 
provided by Dr. Kyoungho Suk at Kyungpook National 
University, South Korea. BV2 cells were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) (Welgene) 
supplemented with 10% heat-inactivated fetal bovine serum 
(FBS) (Omega Scientific Inc), and 100 U/mL penicillin and 
100 μg/mL streptomycin (Thermo Fisher Scientific).
Middle cerebral artery occlusion (MCAO)
MCAO procedures were carried out as described 
previously [29]. Briefly, a silicon suture (Doccol 
Corporation) was used to occlude perfusion in the left 
MCA for 60 min, followed by removal of the suture and 
terminal ligation of the left carotid artery. Sham animals 
were similarly ligated for the left carotid artery. Blood 
perfusion before or during occlusion was measured 
by using Laser Doppler (PIM3, PERIMED) in the 
anesthetized mice that had been pre-warmed to the core 
body temperature of 38 °C on a heating plate measured by 
a rectal temperature probe (Physitemp).
Triphenyltetrazolium chloride staining
The brain of euthanized animal was removed and 
transferred to an acrylic brain matrices (Leica Biosystems) 
and sectioned at 2 mm thickness from the frontal to the 
occipital pole. The slices were then immersed in 2% 
2,3,5-triphenyltetrazolium chloride (Sigma) in phosphate 
buffered saline (PBS) and further incubated at room 
temperature for 15 min, followed by fixation with 4% 
paraformaldehyde (PFA) (DaeJung Chemicals) for 30 
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min. The brain slices were placed on transparent films and 
scanned with EPSON perfection V700 PHOTO scanner.
Behavioral tests
Open-field test was performed based on the 
apparatus and procedure used by Crusio and Schweglar 
[30] with modifications. Briefly, mice were placed in an 
open box allowing to move freely for 10 min. Location 
and accumulated travelled distance for each mouse were 
recorded by a closed circuit digital camera and analyzed 
by using SMART software (Panlab). Rotarod test (Panlab) 
was performed with the rod of 50 mm in the width and 
30 mm in the diameter. Mice were positioned on the rod 
heading in the opposite direction to the rotation. In a test 
session, mice were placed on the rods set to accelerate 
from 4 to 40 rpm during 5 min. Test runs were repeated for 
five times per day and the mean rotational velocities were 
recorded at the time of the fall.
Immunostaining
Mice were cardiac perfused with 4% PFA (Daejung 
Chemicals) in PBS and the brain was harvested and made 
into frozen sections, followed by fixation using ice-cold 
100% methanol for 10 min at the room temperature. 
Sections were then incubated with antibodies against Iba-
1 (goat anti-mouse Iba-1 polyclonal antibodies, Abcam), 
CD68 (rat anti-mouse CD68 monoclonal antibodies, 
Abcam), HIF-1α (goat anti-rabbit HIF-1α antibodies, 
Novus), NeuN (rabbit anti-mouse NeuN antibodies, 
Abcam), DCX (rabbit anti-mouse DCX antibodies), 
Ki67-FITC (Biolegends), caspase-3 (rabbit anti-mouse 
antibodies, Abcam), or cleaved caspase-3 (CC3, rabbit 
anti-mouse CC3 antibodies, Cell signaling technology) 
antibodies for overnight at 4°C. Secondary antibodies 
of species-matched IgG conjugated with Alexa 488 and/
or Alexa 546 (Thermo Fisher Scientific) were incubated 
for 1 hr at the room temperature. Sections were finally 
mounted with ProLong Gold antifade reagent with DAPI 
(Invitrogen) and examined with Zeiss Axio Scope with 
EC PLAN NEOFLUAR at 10×, 20×, and 40× objective 
lenses. Digital images were taken using AxioCam HRM 
camera and processed with AxioVision 4.8 software using 
20× objective fluorescence microscope as described 
above. Images were evaluated at least three independent 
areas per mouse. Area densities were calculated by Image 
J software (National Institutes of Health).
Fluorescence-activated cell sorting (FACS)
FACS procedures for microglia were performed 
as previously described [31]. In brief, left hemisphere 
including the infarct region of the brain was harvested from 
WT or Hif-1α KO mice and digested in an enzyme cocktail 
followed by introduction to Percoll (GE Healthcare) 
gradient (30%, 37%, and 70% Stock Isotonic Percoll 
balanced with Hanks balanced salt solution (Invitrogen). 
Microglia enriched at 70% - 37% interphase were then 
collected and stained with Iba-1 antibodies as described 
in the ‘immunostaining’ procedure. Cells were finally 
resuspended in PBS + 3% FBS (Invitrogen) containing 
propidium iodide and analyzed by BD LSR II (BD 
Biosciences) or sorted by MoFlo XPD (Beckman Coulter).
Phagocytosis assay
BV2 murine microglial cell line or purified primary 
microglia by FACS were plated at a density of 5 × 104 
and 2 × 105 cells, respectively, on poly-D-lysine-coated 
8 chamber polystyrene vessel tissue culture treated glass 
slide (BD Falcon). Cells were left to adhere overnight in 
DMEM at 37 °C under 20% O2 with 5% CO2 followed 
by stimulation with 100 ng/mL LPS (Calbiochem), 50 
ng/mL IFN-γ (Peprotech), 20 ng/mL IL-4 (Peprotech), 
or 150 μM CoCl2 (Sigma) for 6 hr. 3 μL of 1:10 diluted 
(1.1 × 109 beads) 1 μm carboxylate-modified fluorescent 
microspheres (Invitrogen) were added and incubated 
for another 2 hr at 37 °C under 20% O2 with 5% CO2. 
Following incubation, medium was removed and ice-cold 
PBS was added to arrest the bead uptake. Cells were then 
fixed with 4% PFA, chambers were removed, and slides 
were mounted with Prolong Gold antifade reagent and 
analyzed by fluorescence microscopy as described above. 
The number of beads ingested per cell were counted for 
100 cells from at least three independent experiments.
Quantitative real-time polymerase chain reaction 
(qRT-PCR)
Genomic DNA was purified by using the PureLink 
Genomic DNA kit (Bioneer) from microglia sorted by 
FACS. Gene deletion efficiency was determined by qRT-
PCR (OneStepPlus; Applied Biosystems) using the following 
primers: Hif-1α Fwd 5′-GGT GCT GGT GTC CAA AAT 
GTA G-3′ and Hif-1α Rev 5′ ATG GGT CTA GAG AGA 
TAG CTC CAC A -3′, β-actin Fwd 5′-AGA GGG AAA TCG 
TGC GTG AC-3′, β-actin Rev 5′-CAA TAG TGA CCT GGC 
CGT-3′. Genomic DNA level was normalized to β-actin. Total 
mRNA was isolated from FACS-purified microglia using 
RNeasy mini kit (QIAGEN) according to the manufacturer’s 
protocol. cDNA was synthesized using the following 
reagents: RNase-free DNase I (Promega), SUPERasein 
(Ambion), EDTA (Promega), dNTP (Invitrogen), random 
primers (Invitrogen), and Reverse Transcriptase (Promega). 
Synthesized cDNA was then subjected to PCR amplification 
using SYBR GREEN (Applied Biosystems) with primers 
listed below. mRNA levels were calculated by relative 
quantification using comparative threshold cycle values 
based on those of β-actin according to the manufacturer’s 
instructions (Applied Biosystems). Primer sequences were: 
Cdc42, 5’- TAC TGC AGG GCA AGA GGA TT -3’ and 5’- 
GTC CCA ACA AGC AAG AAA GG -3’; Cd36, 5’-GTC 
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CTG GCT GTG TTT GGA -3’ and 5’- GCT CAA AGA TGG 
CTC CAT TG -3’; Cx3cr1, 5’- CAC CAT TAG TCT GGG 
CGT CT -3’ and 5’- GAT GCG GAA GTA GCA AAA GC 
-3’; Hif-1a, 5’- CAA GAT CTC GGC GAA GCA A -3’ and 
5’- GGT GAG CCT CAT AAC AGA AGC TTT -3’; Hif-2a, 
5’- CAA CCT GCA GCC TCA GTG TAT C -3’ and 5’- CAC 
CAC GTC GTT CTT CTC GAT -3’; hS100A8, 5’- CCA ATT 
CTC TGA ACA AGT TTT CG -3’ and 5’- TCA CCA TGC 
CCT CTA CAA GA -3’; Il-1β, 5’- GAG AAC CAA GCA 
ACG ACA AAA TAC C -3’ and 5’- GCA TTA GAA ACA 
GTC CAG CCC ATA C -3’; Il-10, 5’- GAT GCC CCA GGC 
AGA GAA -3’ and 5’- CAC CCA GGG AAT TCA AAT GC 
-3’; Lrp1, 5’- GAC AGC AAA CGA GGC CTA AG -3’ and 
5’- ACA GGG GTT GGT CAC TTC AG -3’; Mfg-e8, 5’- 
TTC TGT GAC TCC AGC CTG TG -3’ and 5’- TGG CAG 
ATG TAT TCG GTG AA -3’; Rac1, 5’- TAT GGG ACA 
CAG CTG GAC AA -3’ and 5’- ACA GTG GTG TCG CAC 
TTC AG -3’; Rhoa, 5’- TGG TTG GGA ACA AGA AGG 
AC -3’ and 5’- ACA AGA TGA GGC ACC CAG AC -3’; 
Sirp1α, 5’- TCA GTA ATG TCA CCC CAG CA -3’ and 5’- 
ACC CCT TGG CTT TCT TCT GT -3’; Tgfβ, 5’- TGG AGC 
AAC ATG TGG AAC TC -3’ and 5’- CAG CAG CCG GTT 
ACC AAG -3’; Tnfa, 5’- CGA GTG ACA AGC CTG TAG 
CC -3’ and 5’- GGT TGA CTT TCT CCT GGT ATG AG 
-3’; Trem2, 5’- TAT GAC GCC TTG AAG CAC TG -3’ and 
5’- AGA GTG ATG GTG ACG GTT CC -3’; Vnr, 5’- GAT 
GGC TGC GTA TTT TGG AT -3’ and 5’- TGG AAG TCT 
CCC ACT GCT CT -3’.
TNF-ɑ ELISA
TNF-ɑ levels were measured by ELISA at 6 and 12 
hr in the supernatants of primary microglia isolated from 
WT or Hif-1α KO mice at d5 post-MCAO or from BV2 
cells by using mouse TNF-ɑ Quantikine ELISA System 
(R&D Systems) according to the manufacturer’s protocol.
ROS production
DCF-DA (2’,7’-dichlorodihydrofluorescein diacetate; 
Molecular Probes) was used to study the intracellular ROS 
production in BV2 cells and primary microglia. The study was 
performed on poly-D-lysine-coated 8 chamber polystyrene 
vessel tissue culture treated glass slide (BD Falcon), wherein 
the cells were seeded at a density of 1 × 105 cells in 500 μl 
of 10% FBS supplemented medium at 37 °C under 20% O2 
with 5% CO2. After 4 hr of cell attachment, DCF-DA was 
added at a concentration of 10 μM in fresh media 500 μl/
well and incubated for 30 min. Following incubation, the dye 
solution was removed and the cells were washed twice with 
500 μl/well in PBS. DCF-fluorescence was determined by 
fluorescence microscopy and flow cytometry.
siRNA transfection
Murine Hif-1α, Cd36, and Mfg-e8 siRNA were 
purchased from Dharmacon and scramble siRNA from 
Bioneer. siRNA sequences were as follows: mouse Hif-
1α siRNA, 5’-GGA AAG AGA GUC AUA GAA C-3’; 
mouse Cd36 siRNA #1 Sense, 5’-CUG AGU AGG 
UUU UUC UCU U(dTdT)- 3’ and Antisense, 5’-AAG 
AGA AAA ACC UAC UCA G(dTdT)-3’; mouse Cd36 
siRNA #2 Sense, 5’-AGU CAU CAA UGU UCC UAC 
A(dTdT)-3’, Antisense, 5’-UGU AGG AAC AUU GAU 
GAC U(dTdT)-3’; mouse Mfg-e8 siRNA #1 Sense. 5’-
GAC UGU AUA UGA GGA GCA A(dTdT)-3’, Antisense, 
5’-UUG CUC CUC AUA UAC AGU C(dTdT)-3’; 
mouse Mfg-e8 siRNA #2 Sense, 5’-CAG UAU GUG 
GAG UCC UAC A(dTdT)-3’, Antisense, 5’-UGU 
AGG ACU CCA CAU ACU G(dTdT)-3’; Scramble 
siRNA, 5’-AUCCGCGCGAUAGUACGUATT-3’. 
siRNA transfection was performed with Lipofectamine 
RNAiMAX (Invitrogen). In brief, 60 pmol of siRNA were 
mixed with 10 μl of Lipofectamine RNAiMAX in 1ml of 
pure DMEM medium (Welgene). The mixture was added 
to BV2 cells that were 70% confluent in 6-well culture 
dishes without antibiotics. 24 hr after transfection, cells 
were then resuspended in complete DMEM medium, 
incubated for another 24 hr, and used for experiments.
Western blot analysis
Cells were lysed in radioimmunoprecipitation assay 
(RIPA) buffer containing Protease Inhibitor Cocktail 
(Calbiochem). Nuclear and cytoplasmic fractions 
were prepared from the BV2 cells using NE-PER 
reagents [32] according to the manufacturer’s protocol. 
Protein concentrations were determined by BCA assay 
[32]. Samples were loaded on 12% Bis-Tris pre-cast 
polyacrylamide gel (Invitrogen) and transferred to PVDF 
membrane (BIO-RAD). Membrane was then probed with 
antibody against HIF-1ɑ (NB100-449, Novus) followed by 
goat anti-rabbit IgG antibody conjugated with horseradish 
peroxidase (Santa Cruz) and developed with the Pierce 
ECL substrate (Thermo Fisher Scientific).
Statistical analysis
Statistical comparisons of the datasets were 
performed by unpaired, two-tailed Student’s t test, or 
one- or two-way ANOVA using Prism software (Version 
4.00; GraphPad Inc.). Data were considered statistically 
significant when P < 0.05.
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